000 01384 a2200349 4500
005 20250513203039.0
264 0 _c20000307
008 200003s 0 0 eng d
022 _a0277-3732
024 7 _a10.1097/00000421-200002000-00011
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBooser, D J
245 0 0 _aContinuous-infusion high-dose leucovorin with 5-fluorouracil and cisplatin for relapsed metastatic breast cancer: a phase II study.
_h[electronic resource]
260 _bAmerican journal of clinical oncology
_cFeb 2000
300 _a40-1 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCisplatin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aLeucovorin
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
700 1 _aWalters, R S
700 1 _aHolmes, F A
700 1 _aHortobagyi, G N
773 0 _tAmerican journal of clinical oncology
_gvol. 23
_gno. 1
_gp. 40-1
856 4 0 _uhttps://doi.org/10.1097/00000421-200002000-00011
_zAvailable from publisher's website
999 _c10637358
_d10637358